Biohaven shares plunge after US FDA declines to approve brain disorder drug
Biohaven .(US:BHVN) Reuters·2025-11-05 23:02Shares of Biohaven fell more than 40% on Wednesday after the U.S. Food and Drug Administration declined to approve its experimental treatment for a rare brain disorder. ...